Satsuma Pharmaceuticals Inc (STSA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 64080

Satsuma Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutic products for the acute treatment of migraine. Satsuma Pharmaceuticals serves customers in the State of California.

Data as of 2020-11-22
Market Cap78.226 Million Shares Outstanding17.422 Million Avg 30-day Volume326.558 Thousand
P/E Ratio2.3 Dividend Yield EPS1.92
Price/Sales Price cash flow ratio Price free cash flow ratio-1.9
Book Value4.76 Price to Tangible Book0.94 Alpha-0.03
Short Interest Ratio % Short Interest to Float R-squared0.061097
BETA1.19318 52-week High/Low36.105 / 3.5 Stddev0.319982
View SEC Filings from STSA instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 2 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 46 52 -11.54% 16 (1.05%) 17 (1.1%) -5.88%
13F shares: 9.789 Million 13.764 Million -28.88% 6.233 Million 9.325 Million -33.16%
% Ownership 56.2279 79.1521 -28.96% 35.8019 53.6258 -33.24%
New Positions: 14 18 -22.22% 10 9 11.11%
Increased Positions 10 21 -52.38% 2 4 -50.0%
Closed Positions 20 3 566.67% 11 1 1000.0%
Reduced Positions 15 7 114.29% 3 3 0.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding STSA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STSA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

O'NEIL THOMAS P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-09-01 8

ALBRECHT DETLEF CHIEF MEDICAL OFFICER

  • Officer
20,212 2020-09-01 11

SOLOWAY THOMAS P

  • Director
0 2020-07-02 2

LUKATCH HEATH

  • Director
0 2020-06-29 2

KING THOMAS BRAXTON

  • Director
0 2020-06-12 1

SANDOVAL ELISABETH

  • Director
0 2020-06-12 1

TAKANASHI KEN

  • Director
1,561,719 2020-06-12 1

RIEBE MICHAEL T

  • Director
0 2020-06-12 1

SHAH RAJEEV M.

  • Director
  • 10% Owner
4,681,858 2020-06-12 1

KOLLINS JOHN A PRESIDENT AND CEO

  • Officer
  • Director
0 2020-03-04 1

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
4,681,858 2019-09-17 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

  • 10% Owner
1,105,154 2019-09-17 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
1,885,939 2019-09-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments